Marcaine Injection, Solution
Product Images NDC 0404-9779

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Marcaine (NDC 0404-9779). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Henry Schein, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula1.jpg (Formula1)

Chemical structure of bupivacaine hydrochloride, the active ingredient in Marcaine 5 mg/mL injection solution, showing its molecular components including a piperidine ring, amide linkage, and aromatic ring with methyl groups, formed as a hydrochloride hydrate.*

FDA Label Image

Formula2.jpg (Formula2)

Chemical structure diagram showing the molecular formulas of bupivacaine hydrochloride and an associated compound, likely representing a salt or co-crystal form related to the drug Marcaine.*

FDA Label Image

Image1.jpg (Image1)

A data table showing types of nerve blocks and the recommended concentrations of Marcaine (bupivacaine hydrochloride) and Marcaine with epinephrine. It lists different block types including local infiltration, peripheral nerve, retrobulbar, sympathetic, caudal, lumbar epidural, epidural test dose, and dental block, with recommended strengths ranging from 0.25% to 0.75% (2.5 to 7.5 mg/mL) for each formulation. The table includes notes on specific use guidelines and cautions for certain blocks.*

FDA Label Image

Image2.jpg (Image2)

A data table titled 'MARCAINE / MARCAINE WITH EPINEPHRINE Concentration vs. Motor Function' showing effects of different Marcaine concentrations (0.25%, 0.5%, and 0.75%) on motor function. The table explains motor block completeness and suitability for various blocks and procedures with dosage notes and footnotes clarifying epinephrine inclusion and product availability.*

FDA Label Image

Image3.jpg (Image3)

A data table showing recommended concentrations and doses of Marcaine (bupivacaine hydrochloride) with or without epinephrine for various types of blocks in adults, including local infiltration, peripheral nerve block, and retrobulbar block. The table lists concentration, dose volume in mL, mg of Marcaine, and the degree of motor block expected.*

FDA Label Image

Image4.jpg (Image4)

The table presents dosage information for Marcaine (bupivacaine hydrochloride) injection, solution, 5 mg/mL. It details dose ranges for various nerve blocks and epidural uses, including sympathetic block, caudal block, lumbar epidural block, epidural test dose, and dental use, with notes on motor block degrees and epinephrine usage.*

FDA Label Image

Image5.jpg (Image5)

A table titled "Examples of Drugs Associated with Methemoglobinemia" listing drug classes and corresponding examples. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs. Examples include bupivacaine under Local anesthetics, among others.*

FDA Label Image

Image6.jpg (Image6)

A data table presenting unit of sale and concentration details for bupivacaine hydrochloride injection, including various packaging options such as trays and cartons containing single-dose and multiple-dose vials. Concentrations range from 0.25% to 0.5%, with volume and total drug amounts per container listed.*

FDA Label Image

Image7.jpg (Image7)

Data table listing various NDCs and packaging types for bupivacaine hydrochloride injection solutions at different strengths. It includes vial counts, dosage strengths (0.5% and 0.75%), and corresponding total drug amounts (e.g., 150 mg/30 mL, 75 mg/10 mL) in single-dose and multiple-dose vial formats.*

FDA Label Image

Image8.jpg (Image8)

A table listing various units of sale and concentrations for a drug product. It includes different NDC codes with carton sizes for single-dose and multiple-dose vials, and concentrations ranging from 0.25% to 0.5%, specifying total mg per mL quantities and vial volumes.*

FDA Label Image

Label1.jpg (Label1)

Label for Marcaine 0.5% (bupivacaine hydrochloride) injection, solution, 5 mg/mL in 10 mL single-dose vial. The label notes use for nerve block, caudal, and epidural anesthesia, and not for intrathecal anesthesia. It is preservative-free and includes storage instructions between 20°C to 25°C with allowed excursions. Distributed by Henry Schein, Inc., Bastian, VA. The label displays NDC 0404-9779-10 and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.